Security key
747324101
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS)
CUSIP: 747324101
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 62,130,557
- Total 13F shares
- 27,457,764
- Share change
- -2,790,134
- Total reported value
- $30,197,446
- Price per share
- $1.10
- Number of holders
- 74
- Value change
- -$2,879,012
- Number of buys
- 35
- Number of sells
- 52
Report period
Q2 2025
Institutions
74
Top holders
10
PYXS full security history
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Pyxis Oncology, Inc. SEC filings
Pyxis Oncology, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 747324101
Recent filing periods:
Top shareholders of PYXS - Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Lara Sullivan |
13D/G
3/4/5
|
Lara Sullivan, M.D. · President ,CEO & CMO, Director |
11%
|
7,543,007
|
$7,844,727 | +$955,040 | 31 Mar 2025 | |
| INTEGRATED CORE STRATEGIES (US) LLC |
13D/G
|
Millennium Management LLC |
4%
|
2,488,079
|
$2,587,602 | -$698,942 | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
13D/G
|
Company |
1.5%
from 13D/G
|
3,271,974
|
$3,206,208 | — | 31 Mar 2025 | |
| Ridgeback Capital Investments L.P. |
13D/G
|
— |
0.6%
|
359,231
|
$373,600 | $0 | 31 Dec 2024 | |
| PFIZER INC |
3/4/5
13F
|
10%+ Owner · Company |
11%
from 13F
|
7,032,770
|
$19,410,445 | — | 17 Mar 2023 | |
| Laurion Capital Management LP |
13F
|
Company |
5.8%
|
3,625,974
|
$3,553,092 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
4%
|
2,485,276
|
$2,435,322 | — | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
3.9%
|
2,436,728
|
$2,387,994 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.8%
|
1,109,098
|
$1,087,012 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
1.8%
|
1,100,000
|
$1,077,890 | — | 31 Mar 2025 | |
| Palo Alto Investors LP |
13F
|
Company |
1.7%
|
1,037,421
|
$1,016,569 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.5%
|
932,198
|
$913,461 | — | 31 Mar 2025 | |
| Aberdeen Group plc |
13F
|
Company |
1.5%
|
913,045
|
$894,693 | — | 31 Mar 2025 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.99%
|
613,253
|
$600,927 | — | 31 Mar 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.94%
|
582,136
|
$570,435 | — | 31 Mar 2025 | |
| 683 Capital Management, LLC |
13F
|
Company |
0.89%
|
550,000
|
$538,946 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.72%
|
446,482
|
$437,508 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.64%
|
396,844
|
$388,908 | — | 31 Mar 2025 | |
| PIER 88 INVESTMENT PARTNERS LLC |
13F
|
Company |
0.63%
|
390,960
|
$383,102 | — | 31 Mar 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.6%
|
373,716
|
$366,204 | — | 31 Mar 2025 | |
| Decheng Capital LLC |
13F
|
Company |
0.53%
|
326,810
|
$320,241 | — | 31 Mar 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.44%
|
272,769
|
$267,287 | — | 31 Mar 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.29%
|
181,042
|
$177,403 | — | 31 Mar 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.26%
|
160,830
|
$157,597 | — | 31 Mar 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.2%
|
127,304
|
$124,745 | — | 31 Mar 2025 | |
| SCHULHOFF & CO INC |
13F
|
Company |
0.2%
|
122,000
|
$119,547 | — | 31 Mar 2025 | |
| NewEdge Wealth, LLC |
13F
|
Company |
0.19%
|
116,006
|
$113,674 | — | 31 Mar 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.19%
|
115,237
|
$112,921 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.16%
|
96,652
|
$95,000 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0.14%
|
86,655
|
$84,913 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.14%
|
84,122
|
$81,000 | — | 31 Mar 2025 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.13%
|
80,795
|
$79,171 | — | 31 Mar 2025 | |
| Fan Yu |
13F
|
Individual |
0.11%
|
69,303
|
$67,910 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.11%
|
68,156
|
$66,785 | — | 31 Mar 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.1%
|
64,888
|
$63,584 | — | 31 Mar 2025 | |
| Cable Car Capital, LP |
13F
|
Company |
0.1%
|
61,606
|
$60,368 | — | 31 Mar 2025 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.1%
|
61,140
|
$59,911 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
3/4/5
13F
|
10%+ Owner · Company |
0.09%
from 13F
|
3,477,975
|
$4,869,165 | — | 26 Apr 2022 | |
| UNIVERSITY OF CHICAGO |
13F
|
Company |
0.08%
|
48,731
|
$47,752 | — | 31 Mar 2025 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0.07%
|
45,128
|
$44,221 | — | 31 Mar 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.07%
|
43,250
|
$42,000 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.06%
|
40,323
|
$39,476 | — | 31 Mar 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.06%
|
40,270
|
$39,461 | — | 31 Mar 2025 | |
| Verition Fund Management LLC |
13F
|
Company |
0.06%
|
38,260
|
$37,491 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.06%
|
36,516
|
$35,782 | — | 31 Mar 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.06%
|
35,040
|
$34,336 | — | 31 Mar 2025 | |
| INTECH INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.05%
|
32,173
|
$31,526 | — | 31 Mar 2025 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.05%
|
29,890
|
$29,289 | — | 31 Mar 2025 | |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. |
13F
|
Company |
0.05%
|
29,259
|
$28,671 | — | 31 Mar 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.05%
|
28,390
|
$27,822 | — | 31 Mar 2025 |
Institutional Holders of Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) as of Q2 2025
As of 30 Jun 2025,
Pyxis Oncology, Inc. - Common Stock, par value $0.001 per share (PYXS) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,457,764 shares.
The largest 10 holders included
Pfizer Inc, Laurion Capital Management LP, MILLENNIUM MANAGEMENT LLC, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, Palo Alto Investors LP, BlackRock, Inc., Aberdeen Group plc, 683 Capital Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
88
Q2 2025 holders
74
Holder diff
-14
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.